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ABSTRACT Site-directed spin-labeling and electron paramagnetic resonance are powerful tools for studying structure and
conformational dynamics of proteins, especially in membranes. The position of the spin label is used as an indicator of the position
of the site to which it is attached. The interpretation of these experiments is based on the assumptions that the spin label does not
affect the peptide conﬁguration and that it has a ﬁxed orientation and distance with respect to the protein backbone. Here, the
validity of these assumptions is examined through implicit membrane molecular dynamics simulations of the inﬂuenza
hemagglutinin fusion peptide that has been labeled with methanethiosulfonate spin label. We ﬁnd that the methanethiosulfonate
spin label can occasionally induce peptide orientations that differ from those adopted by the wild-type peptide. Furthermore, the
spin-label resides, on average, several A˚ngstroms deeper in the membrane than the corresponding backbone Ca-atom even at
sites pointing toward the solvent. The nitroxide spin label exhibits ﬂexibility and adopts various conﬁgurations depending on the
surrounding residues.
INTRODUCTION
Site-directed spin-labeling combined with electron paramag-
netic resonance (EPR) is a commonly used and powerful tool
for measurements of structure and conformational dynamics
of both soluble and membrane proteins (1–8). The method
involves a site-speciﬁc cysteine mutation, which is typically
labeled with a nitroxide spin label. EPR measurements of the
spectral properties of the paramagnetic unpaired electron in
this spin label provide information about the environment,
such as membrane insertion depth, mobility of the spin label,
polarity of the environment, and distance to another para-
magnetic subgroup in the system (5–9). EPR has been used
for studying protein conformational changes through dis-
tance measurements between two paramagnetic electrons in
a system (10–13), as well as for prediction of backbone dy-
namics (14,15) and to study the membrane insertion depth of
a protein or a peptide and its secondary structure (13,16–19).
The analysis of EPR data in membrane systems is usually
based on the assumption that the spin label adopts a ﬁxed
orientation and distance with respect to the backbone. How-
ever, most spin-label residues are not immobilized by the
surroundings; in fact, the EPR measurements convey infor-
mation about both backbone dynamics and spin-label dy-
namics (4). Furthermore, crystal structures showed that the
spin label may adopt a variety of orientations and confor-
mations with respect to the backbone (20). A recent study
addressed the ﬂexibility issue by combining modeling of the
spin-label orientation and measurements (21), and another
one utilized molecular dynamics simulations to determine
preferred labeling sites (22), but this is rare. The assumptions
of ﬁxed orientation and distance from the backbone become
especially signiﬁcant when the data is employed to predict
secondary structure and insertion depth of a membrane pro-
tein. Site-dependent spin-label conﬁgurations could emerge
with greater likelihood at surface sites and in the presence of
a hydrophobicity gradient, such as at the lipid bilayer-water
interface.
In Macosco et al. (17) and Han et al. (23), site-speciﬁc
mutations and EPR were used to obtain a spin-label insertion
depth proﬁle (24) for the hemagglutinin fusion peptide. The
proﬁle was employed in deducing the membrane insertion
depth and orientation of the labeled peptide with the help of
the assumption that the distance and conﬁguration of the spin
label with respect to the peptide backbone are the same for all
the labeled residues (17,23). Based on methanethiosulfonate
spin-label (MTSSL) measurements, Macosco et al. (17) pre-
dicted an a-helix with a membrane insertion angle of 25 and
membrane insertion depth somewhat deeper than the lipid
phosphate group. Han et al. introduced a hydrophilic exten-
sion tail to the peptide and deduced that the peptide adopts a
V-shaped helix-break-helix conﬁguration that has both the
N- and the C-termini inserted into the membrane (23). Other
studies of the hemagglutinin fusion peptide reported a helical
structure with 45 tilt angle (25), N-terminus insertion depth
close to phosphate headgroup (26), and an orientation along
the membrane-water interface for a glutamic-acid-rich an-
alog (27).
The MTSSL is a relatively long and ﬂexible residue
(20,28) and has been demonstrated to adopt several site-
dependent conformations in crystal structures (20). In addi-
tion, the label is more hydrophobic than the majority of the
residues it replaces (29), and may affect the membrane in-
sertion depth. In this work, we employ molecular dynamics
simulations of the well-studied inﬂuenza hemagglutinin
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fusion peptide, i.e., a 20-residue-long N-terminal sequence
of inﬂuenza hemagglutinin, as a test platform for studying
the conﬁgurational variety of the MTSSL. The spin label is
presented in Fig. 1. The inﬂuenza hemagglutinin fusion pep-
tide was chosen because there are two independent MTSSL-
based studies of membrane orientation of this peptide (17,23)
and also because we (30), and others (31–33), have been
unable to reproduce the proposed orientation based on the
EPR studies. Our simulations predict the peptide to adopt a
slightly tilted orientation along the lipid headgroup-tail
interface (30), whereas Bechor and Ben-Tal (32) predicts an
interfacial orientation, Efremov et al. (31) report an angle
between 10.3 and 18.0 but an insertion depth of only 1.4 A˚
into the lipid headgroup region, and Spassov et al. (33) report
the peptide to reside in the interface at an angle of 20–25 but
only if one helix turn at the N-terminus unwraps—for intact
helix, the orientation was practically parallel to the mem-
brane-water interface. We model the site-speciﬁc MTSSL
mutations of Macosco et al. (17) and Han et al. (23) and
study by molecular dynamics simulations the conﬁgurations
of the mutant peptide and the spin label in the membrane.
The results suggest that the conﬁgurational ﬂexibility of the
spin-label residue should be taken into account in EPR data
analysis.
COMPUTATIONAL METHODS
In Macosco et al. (17), the following mutations were studied: A5C, I6C,
A7C, G8C, I10C, N12C, G13C, and W14C. Here, C refers to the MTSSL-
labeled cysteine residue (see Fig. 1). Han et al. introduced an additional
hydrophilic seven-residue tail to the fusion peptide in their study (23).
Mutations to all except G4 and G8 in the 20-residue fusion peptide sequence
were studied. We reproduce, one by one, the mutations of Macosco et al.
(17) in a 20-residue-long hemagglutinin fusion peptide sequence of inﬂu-
enza strain X31 (GLFGAIAGFIENGWEGMIDG), and the mutations of
Han et al. (23) in the extended 27-residue sequence that adds the artiﬁcial tail
(-GCGKKKK) to the aforementioned sequence. The acidic residues
(underlined) are either deprotonated (charged) or protonated (neutral), and
in the simulations of the extended 27-residue peptide, the native cysteine in
the tail has been replaced by a serine in accord with the experiments (23).
The CHARMM 19 force ﬁeld that treats nonpolar hydrogen atoms
implicitly is employed to describe the intramolecular interactions in the
peptide (34,35). The EFF1.1 implicit description of water and the IMM1
description of the membrane are used to describe the environment (36,37).
The hydrophobic thickness T of the bilayer depends on the type of lipids and
typically ranges between 20 A˚ and 30 A˚. A value of T¼ 26 A˚ has been used
in this work. The CHARMM 19 force ﬁeld (35) and the IMM1 solvation
model (36) do not include parameters for the nitroxyl label. The param-
eterization is presented in Appendix A.
We start by sampling the membrane conﬁgurations of the spin-labeled
inﬂuenza hemagglutinin fusion peptide. The peptide is placed close to, or
into the membrane, as an initially ideal, obliquely inserteda-helix. The initial
insertion angle ranges between 0 and 90 with respect to the membrane at
intervals of 15. Two insertion depths are tried: center of mass initially at z¼
0.0 A˚ (at the center of membrane) or at z ¼ 13.0 A˚ (at the polar-nonpolar
interface). The initial structure is allowed to evolve freely for 500 ps at 300
K, after which the system is minimized for 300 steps by the adopted basis
Newton-Raphson method (34) to obtain comparable initial conﬁgurations.
The use of an implicit environment description provides signiﬁcantly faster
relaxation than all-atom molecular dynamics simulations. The obtained
relaxed conﬁgurations are then simulated for 500 ps by employing the Nose´-
Hoover thermostat with heat bath coupling constant q ¼ 100 (38,39). The
trajectory of the last 400 ps of this part of the simulation is used to char-
acterize the membrane orientation, insertion, and energetics of the peptide.
For each site-labeled mutant, the conﬁguration that corresponds to the
most typical run of the ensemble resulting from the above runs of a particular
mutant is selected and subjected to a 5-ns Nose´-Hoover simulation. This
trajectory is employed to calculate the average membrane insertion depths
and orientations of the spin label and the dihedral angle distributions of the
spin label. The orientations, insertion depths, and dihedral angle distribu-
tions are averaged over simulation frames sampled every 500 steps.
In the simulations, the N-terminus is deprotonated while the acidic res-
idues are protonated or deprotonated. The effective energy values presented
do not include the cost of (de)protonation and the entropic contributions to
the free energy. Therefore, the effective energy values are comparable only
within a given state.
RESULTS
The wild-type HA fusion peptide monomer adopts in the
simulations a slightly tilted orientation along the lipid head-
group-tail interface (Fig. 2). The adopted angle ranges
between 5 and 25 with an average of 12.4 6 4.2 and the
insertion depth corresponds to the N-terminus residing at the
lipid headgroup-tail interface (30).
In the simulations of the spin-labeled peptides, the orienta-
tion and the position of the mutated peptide in the membrane
as well as the depth of the nitroxide spin label in the mem-
brane are monitored for each of the studied mutants. The
simulated peptides adopt the slightly tilted interfacial orien-
tation depicted in Fig. 2 and do not insert into the hydro-
phobic core region of the membrane with the exception of
the 20-residue-long G8C mutant for which the mutation cre-
ates a stable obliquely inserted conﬁguration. The obliquely
inserted conﬁguration of the G8C-mutant is energetically
comparable with the interfacial orientation. The orientations
are shown in Fig. 3. The fact that the energy of the oblique
FIGURE 1 The methanethiosulfonate spin label (MTSSL) attached to
cysteine. The symbols next to the atoms refer to the atom type and partial
charge used in CHARMM. The angles x1–x5 refer to dihedral angles in the
residue. We employ the CHARMM 19 force ﬁeld (35) that treats nonpolar
hydrogens implicitly.
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orientation is comparable to the interfacial orientation
demonstrates that the single point mutation can affect the
energy landscape enough to introduce new stable conﬁgu-
rations. In contrast to the wild-type and other mutants in
which a kink is present in the dynamics of the peptides but
not in the minimized structures, the obliquely inserted G8C
mutant also occasionally shows a stable kink in the mini-
mized fusion peptide structure as shown in Fig. 3.
Figs. 4 and 5 present the average effective energies, in-
sertion depths, and angles with respect to membrane plane
adopted by the fusion peptides in the simulations. For the 27-
residue extended mutants an interesting phenomenon can be
observed: the hydrophilic tail enhances the ﬂuctuations of
the peptide, which is visible as a larger scatter of data points
in Fig. 5 than in Fig. 4. Furthermore, the N-terminal insertion
angle increases in comparison to the 20-residue peptide. All
the mutants of the 27-residue peptide adopt the interfacial
orientation, but we observe two cases in which the mutants
(D19C and A7C) ﬂuctuate from obliquely inserted to
interfacial conﬁgurations indicating an obliquely inserted
local minimum. These special cases are marked in Fig. 5.
Figs. 6 and 7 show how the insertion depths of the
simulated spin labels in the 5-ns-long runs compare with
the measurements of Macosco et al. (17) and Han et al. (23).
The plots show average insertion depths of the spin-label
nitrogen atom and the error bar is the standard deviation of
the nitrogen z-position. Spin labels in some mutants have
several stable orientations and during the dynamics, the spin
label ﬂips back and forth between orientations. This shows as
a larger standard deviation (error bar) in Figs. 6 and 7.
In Fig. 6, the simulated nitroxide label positions are in
excellent agreement with the data of Macosco et al. (17) with
the exception of the I6C mutant for which the experimental
points indicate deeper membrane insertion than observed in
the simulations of the spin label. Typical spin-label orien-
tations for the I6C mutant are shown in Fig. 8 that show the
spin label residing quite close to the peptide backbone.
The measured data point is a few A˚ngstroms deeper in the
FIGURE 2 The slightly tilted orientation adopted by
the hemagglutinin fusion peptide. The yellow plane
represents the lipid tail-headgroup interface and the
gray plane shows the level at which the lipid phosphate
group is estimated to be. Although the peptide is
straight and helical in this minimized structure, the
dynamics of the peptide show that the peptide behaves
in a hingelike fashion: The N-terminus and the
C-terminus form two separate helices. In the ﬁgure,
the acidic residues are uncharged. This ﬁgure, as well
as Figs. 3, 8, 9, and 12, were produced with the
program VMD (46), after which they were rendered
and the planes added with POV-Ray.
FIGURE 3 The spin-label mutation changes the
energy landscape enough for a stable obliquely inserted
orientation to emerge in the 20-residue-long G8C mu-
tant. The oblique orientation is comparable in effective
energy with the interfacial orientation (see Fig. 4).
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membrane. On the other hand, spin labels at mutation site
N12C extend to almost opposite directions in different
conﬁgurations as shown by Fig. 9. The spin label also easily
ﬂips between the orientations, which shows as large standard
deviation (error bars) in Fig. 6. The large standard deviation
for the G8C mutant with protonated acidic residues (Fig. 6,
right side) results from the peptide spending ;20% of the
simulation in the obliquely inserted conﬁguration and the
rest in the interfacial orientation. The same mutant with
charged acidic residues prefers the interfacial orientation but
ﬂuctuates more than the other mutants. The ﬂuctuations at
the W14C-mutant with charged acidic residues result from
some C-terminal unwrapping of the peptide and the spin label
interacting with the unsatisﬁed hydrogen-bonding groups of
the unwrapped terminus.
The 27-residue peptide exhibits a high degree of ﬂuctu-
ations in the tail region. The spin label at the C-terminal half
of the peptide interacts with the lysines of the tail region.
This affects both the position of the spin label and its ﬂuc-
tuations. Often the C-terminal end of the peptide also par-
tially unwrapped. In line with the 20-residue results, the
27-residue peptide simulation points do not reproduce the
points that are deepest in the membrane, i.e., pH 5.0 L2C and
F3C mutants and the W14C mutant. The spin label in the
L2C and in the F3C mutants interacts with the unsatisﬁed
hydrogen-bonding groups at the helix terminus. This is not,
however, sufﬁcient to explain the difference with experi-
ment: if the spin label at these sites did not interact with the
FIGURE 4 Effective energy andN-terminal insertion depth plotted against
the angle with respect to the membrane plane for the spin-labeled hemag-
glutinin fusion peptide. Triangles refer to peptides with charged acidic
residues and squares to peptides with protonated acidic residues. The ener-
gies of the states do not include the cost of (de)protonation and therefore are
comparable only within the same mutant and protonation state. One of the
mutants, G8C, shows a stable low-energy conﬁguration in which the peptide
adopts an oblique orientation.
FIGURE 5 Effective energy andN-terminal insertion depth plotted against
the angle with respect to the membrane plane for the spin-labeled extended
27-residue hemagglutinin fusion peptide. Triangles refer to peptides with
charged acidic residues and squares to peptides with protonated acidic
residues. The energies of the states do not include the cost of (de)protonation
and therefore are comparable only within the same mutant and protonation
state. The symbols indicating deeper membrane insertion in B refer to two
metastable obliquely inserted mutants (A7C, D19C) that switch from oblique
insertion to the interfacial conﬁguration during the simulation.
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N-terminus, it would be only a few A˚ngstroms deeper in the
membrane. The spin label in the pH 5.0 W14C mutant points
mostly toward the membrane center but also spends parts of
the simulation pointing toward the peptide backbone—
should the spin label prefer entirely the former orientation,
the experimental point would be reproduced. This discrep-
ancy in reproducing the data points corresponding to deepest
insertion in the experiments is discussed later from the meth-
odological viewpoint.
The experimental points corresponding to the 27-residue
E11C mutant are somewhat above the simulation points
(Fig. 7). For the E11C mutant, we see the spin label mostly
pointing toward the membrane center instead of away from
it, which would correspond to the experimental data points.
Although our spin label is equally hydrophobic as experi-
mentally measured (see Appendix A), the hydrophobicity
calculation contains a relatively large uncertainty. This may
be enough to destabilize the away-from-membrane-center
orientation that we occasionally see.
As in the 20-residue peptide, the spin label in the N12C
mutant shows high conﬁgurational ﬂexibility pointing at op-
posite orientations. The simulation data for the N12C mutant
at low pH appear to be lower than the experimental point.
This could be due to a sampling deﬁciency of the simulation
at this highly ﬂexible site (the pH 7 simulation data cover the
experimental point).
FIGURE 6 The insertion depth of MTSSL in the 20-residue peptide. The
horizontal bars mark the average insertion depth of the spin-label nitrogen
atom while the vertical bars show the standard deviation of the spin-label
insertion depth. The error bar of experimental data of Macosco et al. (17) is
estimated to be 2 A˚ from the graph given in that study (17). The results of
Macosco et al. (17) have been converted to the coordinate system used in
this work by employing the formula d9 ¼ d 1 16.0 A˚, in which d9 is
plotted above and d is the insertion depth presented in Macosco et al. (17)
and Han et al. (23). This coordinate transformation is necessary because we
deﬁne the origin to be at the center of the membrane instead of at the lipid
phosphate group level. The increment consists of our nonpolar region
thickness T/2¼ 13 A˚ incremented by 3 A˚ for the lipid phosphate headgroup.
FIGURE 7 The insertion depth of MTSSL in the 27-residue extended
peptide. As in Fig. 6, the horizontal bars mark the average insertion depth of
the spin-label nitrogen atom while the vertical bars show the standard
deviation of the spin-label insertion depth. The error bar of experimental data
of Han et al. (23) was reported to be 1.5 A˚ in that study (23). The results of
Han et al. (23) have been converted to the coordinate system analogous to
Fig. 6.
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The large error bars for the C-terminal mutants starting
from G16C result from a variable degree of interaction with
the tail lysines. This causes uncertainty in the predictions of
the C-terminal spin-label position. Curiously, however, we
do not observe the relatively far-from-the-membrane orien-
tation for the M17C mutant spin label. In our simulations, the
M17C spin label prefers to stay in contact with the mem-
brane. There is some evidence that the peptide may have
adopted a 310-helix structure at the C-terminal end in the
experiments (23). Our peptide remains a-helical; a structural
change to a 310-helix would deﬁnitely change the preferred
orientations of some of the spin labels, presumably also
M17C. Because of the tail interactions and occasional un-
wrapping of the C-terminal region, we have large standard
deviations for a majority of the C-terminal mutants and
cannot conclude whether the measurement points would
agree more with a 310-helical backbone.
Table 1 presents the average difference in membrane
insertion depth for the MTSSL nitrogen atom and the Ca-
atom in the peptides, as well as the distance between the two
atoms. In most mutants, the nitrogen label is signiﬁcantly
deeper in the membrane than the backbone Ca-atom, even
for residues on the solvent side of the helix. The table also
shows that the distance between the Ca-atom and the ni-
trogen atom in the spin label varies between 4.3 A˚ and 7.6 A˚.
The small standard deviations show that this distance, i.e.,
the arm length of the residue, is quite ﬁxed within each site;
the difference in insertion depth ﬂuctuates much more. The
largest ﬂuctuations are observed for the N12C mutant for
both peptide lengths, which is also visible in Figs. 6 and 7.
Another ‘‘unstable’’ spin-label site is the 20-residue G8C
mutant that has two competing orientations. In the C-ter-
minal mutants, the ﬂuctuations in depth stand out for the
27-residue E15C, G16C, I18C, and D19C mutants when the
acidic residues are charged. The protonation of the acidic
residues stabilizes the C-terminal half of the peptide.
Figs. 10 and 11 show the dihedral-angle probability distri-
butions of MTSSL in peptides with charged acidic residues.
The distributions show that the peaks corresponding to high
probability angles may vary in position signiﬁcantly between
different mutation sites. Some trends can be observed:
typically, the angle x1 has a trans-orientation but may also
FIGURE 8 Typical spin-label orientations in the
20-residue-long I6C mutant.
FIGURE 9 Typical spin-label orientations in the
20-residue-long N12C mutant. The N-terminus is
toward the left.
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adopt gauche-orientation (g-) in some environments. The
angle x2 has two preferred orientations. The distribution is
also wider than in the case of x1. The disulﬁde dihedral angle
x3 is relatively ﬁxed at ;90 except for a couple of cases in
which the distribution ﬂips to the corresponding negative
values. The angles x4 and x5 show most ﬂexibility in their
distributions. Their barriers appear to be the smallest, in-
dicating that most ﬂuctuations are due to these two angles in
accordance with Langen et al. (20) and Columbus et al. (40).
However, x1 and x2 are the major contributors in the site-
dependent orientation of the residue. Figs. 8, 9, and 12 show
examples of spin-label orientations at different mutation
sites.
DISCUSSION
The molecular dynamics simulations reported here show that
the assumptions made to simplify the analysis of spin-label-
based EPR measurements have limitations. We ﬁnd that the
commonly used MTSSL may induce new membrane con-
ﬁgurations for the labeled peptide. We observed one of the
studied inﬂuenza hemagglutinin fusion peptide mutants,
namely the 20-residue-long G8C mutant, to adopt also an
obliquely inserted membrane orientation that clearly differed
from the slightly tilted interfacial orientations obtained for
the wild-type and the majority of the mutants. For several
other mutants, we observed the obliquely inserted conﬁgu-
ration as a local minimum upon spin-labeling. For the wild-
type peptide, this minimum was not observed.
Furthermore, because MTSSL is relatively hydrophobic, a
clear bias toward deeper membrane insertion than the cor-
responding backbone Ca-atom was observed for the spin
label. On the average, the nitrogen atom in the spin label is
several A˚ngstroms deeper in the membrane than the cor-
responding Ca even for sites facing the solvent. MTSSL was
also observed to show site-dependent orientations and ﬂexi-
bility in accordance with the crystal structures of Langen
et al. (20), in which several MTSSL orientations are ob-
served depending on the site of mutation, and with Owenius
et al. (28), in which the local environment is reported to
change the spin-label response in a label-dependent manner.
The studied MTSSL residue adopts conﬁgurations in which
the difference between shortest and longest arm lengths is
3.3 A˚. Considering that the arm length was observed to vary
between 4.3 A˚ and 7.6 A˚ in the study, the site-to-site
variance can be .30% from any sensible ﬁxed-arm-length
value.
Macosco et al. (17) and Han et al. (23) provide MTSSL-
based experimental results of the membrane insertion and
orientation with respect to membrane for the inﬂuenza
hemagglutinin fusion peptide. From the data of Macosco
et al. (17) an insertion angle of 25 (pH 7.0) or 28 (pH 5.0)
was deduced while the N-terminal insertion depth was re-
ported to be close to the phosphate headgroup level (17,26).
Han et al. (23) predicted a helix-break-helix conﬁguration in
which both the N-terminus and the C-terminus insert deep
into the hydrophobic core of the membrane. The N-terminal
helix was reported to adopt an angle of 21 or 37 depending
on pH with respect to membrane plane. Experimental studies
based on methods other than MTSSL for deducing the
inﬂuenza hemagglutinin fusion peptide conﬁguration in
membrane predict the peptide to adopt an a-helical form
with an angle of 45 (25) or take a parallel-to-membrane
orientation (27). Both studies predict an interfacial insertion
depth. We observe in the simulations the peptide to adopt a
slightly tilted orientation at the lipid headgroup-tail interface
(30). The tilt angle of 12.4 is less than the tilt angles reported
based on experiments with the exception of Dubovskii et al.
(27), but in line with existing simulation studies (31–33,41–
43); see also the discussion in Sammalkorpi and Lazaridis
(30).
The simulations of the spin-labeled mutants show that
with the exception of the I6C mutant, the spin-label positions
reproduce the measurements of Macosco et al. (17). From
these data, a more tilted orientation was deduced. The ob-
served interfacial insertion depth relates well with the
TABLE 1 Relative membrane insertion Dz ¼ zNsl  zCa and the
spin-label distance DR from the corresponding Ca-atom
20-Residue
Mutant Dz (A˚) sz, 20 (A˚) DR (A˚) sR, 20 (A˚)
A5C 5.95 (5.19) 1.15 (1.76) 7.47 (7.00) 0.45 (0.90)
I6C 4.72 (5.51) 1.57 (1.61) 6.16 (6.64) 1.09 (1.11)
A7C 2.56 (3.50) 1.00 (1.32) 4.98 (5.41) 0.60 (0.92)
G8C 0.19 (2.71) 3.56 (3.01) 6.55 (6.66) 0.95 (0.84)
I10C 5.43 (5.81) 1.87 (1.28) 7.00 (6.75) 0.96 (0.94)
N12C 1.89 (2.40) 4.42 (3.66) 6.99 (6.73) 0.65 (0.68)
G13C 5.94 (6.63) 1.46 (1.39) 7.22 (7.37) 0.83 (0.93)
W14C 5.31 (4.50) 1.78 (3.52) 6.89 (7.18) 0.91 (0.98)
27-Residue
Mutant
Dz (A˚) sz27 (A˚) DR (A˚) sR,27 (A˚)
G1C 2.98 (3.82) 0.95 (1.12) 4.33 (5.11) 0.30 (0.60)
L2C 4.29 (4.95) 1.59 (1.81) 5.38 (6.42) 1.31 (1.33)
F3C 5.22 (5.58) 1.84 (1.34) 6.61 (6.75) 0.82 (0.57)
A5C 2.89 (5.54) 1.61 (1.54) 5.71 (7.39) 0.84 (0.67)
I6C 5.17 (5.17) 1.45 (1.30) 6.81 (6.12) 0.78 (1.00)
A7C 3.52 (3.01) 1.20 (1.11) 5.34 (5.00) 0.79 (0.57)
F9C 5.52 (4.96) 1.83 (1.86) 7.27 (7.21) 0.85 (0.81)
I10C 5.94 (5.80) 1.43 (1.51) 7.15 (7.05) 0.80 (0.91)
E11C 4.60 (4.27) 1.46 (1.67) 6.24 (6.33) 0.77 (0.85)
N12C 2.44 (0.50) 3.67 (4.10) 7.01 (7.07) 0.64 (0.78)
G13C 6.29 (6.10) 1.61 (1.33) 7.48 (7.42) 0.71 (0.66)
W14C 5.67 (6.29) 1.31 (0.76) 6.91 (6.83) 0.90 (0.58)
E15C 5.52 (4.57) 1.48 (2.12) 6.72 (7.56) 0.39 (0.72)
G16C 1.72 (3.23) 4.65 (4.13) 6.76 (7.16) 1.02 (0.69)
M17C 6.42 (6.06) 0.91 (1.72) 7.54 (7.47) 0.61 (0.69)
I18C 6.37 (5.18) 1.11 (2.51) 7.27 (7.49) 0.69 (0.49)
D19C 5.15 (5.00) 0.94 (2.75) 5.96 (6.81) 0.86 (0.81)
G20C 6.02 (6.61) 1.43 (1.51) 7.18 (7.59) 0.92 (0.71)
Standard deviations sz and sR describe the ﬂuctuations. The quantities in
parentheses correspond to peptides with charged acidic residues whereas
the numbers outside the parentheses correspond to peptides with neutralized
acidic residues.
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N-terminal insertion depth reported in Macosco et al. (17)
and Zhou et al. (26). In Han et al. (23), an extended 27-
residue peptide with spin-labeling also in the C-terminal half
of the peptide was studied. Our simulations are able to re-
produce most of the measurement data points of Han et al.
(23), based on which the V-shaped structure with both ter-
mini deep in the hydrophobic core of the membrane was
reported. However, the experimental data points of some
residues, namely the most deeply inserted pH 5.0 L2C, F3C,
and W14C are not reproduced, as well as the E11C and
M17C mutants at both pH values. Some of the deep insertion
experimental data points, i.e., I6C in the 20-residue peptide
and the W14C in the 27-residue peptide, would be possible
to reproduce with a more extended spin-label conformation,
without a change in helix orientation. Other points, however,
such as the N-terminal mutants L2C and F3C at pH 5.0 in the
27-residue peptide, seem to require a more oblique orienta-
tion or deeper membrane insertion of the helix.
The inability to reproduce the deepest spin-label points
may be due to the limitations of the implicit membrane model.
IMM1 is a highly simpliﬁed model of a lipid bilayer and
assumes a perfectly ﬂat, nondeformable membrane. Lagu¨e
et al. (43), in which the membrane is described explicitly in
the simulation, shows the lipids making room for the peptide
and creating a crevice in the membrane upon the fusion pep-
tide binding. This crevice may be enough to enable the spin
label to insert deeper into the membrane when the residue is
oriented toward the membrane-center. The IMM1 descrip-
tion is unable to reproduce the opening of a crevice, which
may contribute to the failure to reproduce the deeply inserted
spin-label position. Alternatively, there may be caveats with
the experimental approach. The polarity gradient assumed by
the collision gradient method (24) may be affected by the
presence of a peptide adsorbed on the membrane surface. For
example, hydrophobic peptide side chains may affect the
distribution of O2 in the membrane. In addition, steric hin-
drance by the peptide may affect access of the polar NiEDDA
to the spin label so that the latter will appear deeper than it
really is.
Although there is some support for the kinked structure
(41–44), the spin-label depth proﬁle at the C-terminal end in
Han et al. (23) can also be explained by the ﬂexibility of the
MTSSL with the exception of the M17C mutant. For the
M17C mutant, the reason for not reproducing the experi-
mental data point may lie in the prediction of Han et al. (23)
that the C-terminal part of the peptide would form a short
310-helix. As we employ an initially a-helical structure, we
might overlook the potential transformation to a 310-helix. It
FIGURE 10 Dihedral-angle distributions of MTSSL residue at different mutation sites of the 20-residue peptide. The distributions correspond to peptides
with charged acidic residues. The plotted dihedral angles are the N – Ca – Cb – S (x1), Ca – Cb – S – S (x2), Cb – S – S – C (x3), S – S – C – C (x4), and S – C – C
– C (x5) (see Fig. 1).
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FIGURE 11 Dihedral-angledistributionsofMTSSLresidueatdifferentmutationsitesof the27-residuepeptide.Thedistributionscorrespond topeptideswithcharged
acidic residues. The plotted dihedral angles are theN –Ca –Cb – S (x1),Ca –Cb – S – S (x2),Cb – S – S –C (x3), S – S –C –C (x4), and S –C –C –C (x5) (see Fig. 1).
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should be noted that, in our force ﬁeld, a-helices are sig-
niﬁcantly more stable than 310 helices.
The timescale of the simulations (5 ns) seems short com-
pared to the experimental timescales. It should be noted, how-
ever, that the true timescale of implicit solvent simulations is
at least an order-of-magnitude longer than the nominal time
due to absence of solvent friction. Still, the high ﬂexibility of
the spin label for some mutants led to relatively large error
bars in the average position of the label, which indicates that
the distribution of the label is not fully converged. These
spin-label position ﬂuctuations are probably fast compared to
the timescale of the EPR experiment so that the measured
positions correspond to averages.
We conclude that MTSSL has a clear hydrophobic inser-
tion bias; it exhibits a high degree of site-dependent ﬂexi-
bility; and the spin-labeling may induce new conﬁgurations
for the labeled peptide. Although the observed spin-labeling
induced conﬁgurations in which the labeled peptide inserted
into the membrane may be local minima, their emergence
indicates that care should be exercised when assuming that
the spin-labeling does not change the conﬁguration of the
labeled peptide. Especially short, amphiphilic peptides may
undergo such conﬁgurational changes upon spin-labeling
and membrane interaction. Furthermore, the ﬂexibility and
site-dependent orientations of the spin label should be taken
FIGURE 12 Typical spin-label orientations in the
20-residue-long W14C mutant. The N-terminus is to-
ward the right. The second ﬁgure shows that the spin-
label may also interact with the terminus, although the
conﬁguration presented above is more typical.
TABLE 2 CHARMM parameters for the MTSSL residue:
parameters for the bond-energy function 12kb b  b0ð Þ2
Type Type
½kb
Kcal mol1 A˚2 b0 A˚ Source
NO CR 350.0 1.502 (45)
NO ON 520.0 1.277 (45)
CR CR 450.0 1.38 Adopted C–C from (35)
CR CR1E 450.0 1.38 Adopted C–CR1E from (35)
CR CH2E 405.0 1.52 Adopted C–CH2E from (35)
CR CH3E 405.0 1.52 Adopted C–CH3E from (35)
CH2E S 450.0 1.81 Adopted CH2E–SH1E from (35)
S S 500.0 2.02 Adopted SH1E–SH1E from (35)
TABLE 3 CHARMM parameters for the MTSSL residue:
parameters for the bond-angle energy function 12ku u u0ð Þ2
Type Type Type
½ku
Kcal mol1
u0
Degrees Source
CR CR NO 20.0 109.45 (45)
CR NO CR 24.0 124.0 (45)
CR NO ON 73.0 118.0 (45)
CR CR1E CR 70.0 122.5 Adopted
C–C–CR1E from (35)
CR1E CR CH3E 70.0 106.5 Adopted C–C–C or
C–CH1E–CH3E from (35)
CH3E CR CH3E 70.0 106.5 Adopted C–C–C or
C–CH1E–CH3E from (35)
CR CR CH3E 70.0 122.5 Adopted
C–C–CR1E from (35)
CR CR NO 20.0 109.45 (45)
CR1E CR NO 20.0 109.45 Adopted
CR-CR-NO from (45)
CH3E CR NO 20.0 109.45 Adopted
CR-CR-NO from (45)
S CH2E CR 50.0 112.5 Adopted
CH–CH2 SH1E from (35)
CH2E S S 50.0 104.2 Adopted
CH2E–SH1E–SH1E (35)
CH2E CR CR1E 70.0 121.5 Adopted
CH2E–C–CR1E from (35)
CR CR CH2E 65.0 126.5 Adopted
C–C–CH2E from (35)
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into account as potential sources of error. Perhaps the accu-
racy of spin-label-based EPR measurements could be im-
proved by combining modeling to measurements as done in
Baumann et al. (21) or by performing the measurements
using two different spin labels and knowledge of the physical
properties of each label.
APPENDIX A: A PARAMETRIZATION OF THE
NITROXIDE SPIN LABEL
The CHARMM 19 force ﬁeld (35) and the IMM1 environment description
(36,37) do not contain parameters for the MTSSL. The necessary force
constant parameters for the nitroxide group were obtained from Morelon
et al. (45), where the parameters for a similar nitroxide label were derived
based on ab initio calculations. The carbon-carbon parameters were deduced
from analogous existing parameters (35). The necessary partial charges for
the nitroxide group were obtained fromMorelon et al. (45), and the resulting
charge is neutralized by the two sp3-coordinated carbon atoms neighboring
the nitrogen, NO. The employed CHARMM parameter values for this
nitroxide label are shown in Tables 2–5. In the tables, the atom types are
referred to in the same way as in the CHARMM program. The atom type CR
is identical to atom type C except for IMM1 solvation parameters that are
presented in Lazaridis (36).
IMM1 solvation parameters of the proline nitrogen have been used for
the nitrogen atom in the nitroxide label, NO. In the membrane environment
the nitroxide oxygen ON shares the solvation parameters of the carbonyl
oxygen. However, the oxygen in the spin label is signiﬁcantly less polar.
Therefore, the ON solvation parameters in water were decreased by 20%
from those of the carbonyl oxygen. To assess the accuracy of this estimated
reduction we compared the hydrophobicity of the MTSSL residue and LEU
residue. The hydrophobicity was computed as the effective energy differ-
ence of a single residue in water and at the water-membrane interface with
the side chain embedded into the nonpolar membrane environment. The
residue was ﬁrst placed at the hydrophobic-hydrophilic interface, relaxed for
100 ps at 300 K, and then minimized by using the adopted basis Newton-
Raphson method (34). This was repeated for different initial velocity
assignments and the average effective energy of 20 relaxed and minimized
structures was used as the effective energy of the residue at the interface or in
water. For the LEU residue, the effective energy difference calculated in this
way was 1.976 0.85 kcal/mol in favor of the interfacial position whereas for
the MTSSL residue we obtained a difference of 2.706 0.89 kcal/mol also in
favor of the interfacial position. The error has been estimated by the standard
deviation of the effective energy values. That is, we found that the MTSSL
TABLE 4 CHARMM parameters for the MTSSL residue: parameters for the dihedral angle energy function 12kf 11cosðnf dÞ½ 
Type Type Type Type ½kv Kcal/mol n d Degrees Source
CR CR NO ON 0.118 3 0.0 (45)
CR1E CR NO ON 0.118 3 0.0 Adopted C–C–NO–ON from (45)
CH3E CR NO ON 0.118 3 0.0 Adopted C–C–NO–ON from (45)
CR CR NO CR 0.118 3 0.0 (45)
CR1E CR NO CR 0.118 3 0.0 Adopted C–C–NO–C from (45)
CH3E CR NO CR 0.118 3 0.0 Adopted C–C–NO–C from (45)
CR1E CR CR NO 0.158 3 0.0 (45)
CR CR1E CR NO 0.158 3 0.0 Adopted C–C–C–NO from (45)
CH2E CR CR NO 0.158 3 0.0 Adopted C–C–C–NO from (45)
CH2E CR CR CH3E 5.0 2 180.0 Adopted C–CR–CR–C from (35)
CR1E CR CR CH3E 5.0 2 180.0 Adopted C–CR–CR–C from (35)
CH2E CR CR CR1E 5.0 2 180.0 Adopted C–CR–CR–C from (35)
CH2E CR CR CR 5.0 2 180.0 Adopted C–CR–CR–C from (35)
CH2E CR CR1E CR 5.0 2 180.0 Adopted C–CR–CR–C from (35)
X CR CR1E X 0.0 3 0.0 Adopted X–C–CH–X from (35)
X CR1E CR1E X 1.6 3 0.0 Adopted X–CH–CH–X from (35)
TABLE 5 CHARMM parameters for the MTSSL residue:
parameters for the improper dihedral energy function
1
2kv vv0ð Þ2
Type Type Type Type
½kv
Kcal/mol
rad2
v0
Degrees Source
CR CR1E CR CH2E 90.0 0.0 Adopted C–CR1E–C–CH2E
from (35)
CR X X CR 25.0 0.0 Adopted CR1E–X–X–CR1E
from (35)
CR X X CR1E 25.0 0.0 Adopted CR1E–X–X–CR1E
from (35)
CR X X CH3E 25.0 0.0 Adopted C–X–X –CH3E
from (35)
NO X X CR 25.0 0.0 Adopted NR–X–X–C
from (35)
NO X X ON 25.0 0.0 Approximated based on
existing (35) nitrogen
and oxygen parameters
The improper torsion angle v is deﬁned for a set of particles (A,B,C,D) as
the angle between the planes ABC and BCD.
TABLE 6 The parameters required for the nitroxide spin label
in the solvation model
Volume
A˚3
Gref
Kcal/mol
Gfree
Kcal/mol
Href
Kcal/mol
CP
ref
cal/mol
NOH2O 4.4 1.000 1.550 1.250 8.80
NOchex 4.4 1.145 1.720 1.843 0.00
ONH2O 10.8 4.337 4.740 4.687 7.13
ONchex 10.8 1.270 1.390 2.045 0.00
For the nitrogen, the solvation parameters of proline nitrogen have been
adopted. The oxygen atom in the label is otherwise analogous to carbonyl
oxygen but less polar. This has been taken into account by reducing the
magnitude of the solvation parameters by 20% in water. The original
proline nitrogen and the carbonyl parameterization is presented in Lazaridis
(36).
20 Sammalkorpi and Lazaridis
Biophysical Journal 92(1) 10–22
residue is 0.73 6 1.2 kcal/mol more hydrophobic than a leucine residue,
which compares well with the 0.7 kcal/mol difference reported in Yu et al.
(29), although there is a substantial statistical uncertainty. The solvation
parameters that differ from those published in Lazaridis (36) are presented in
Table 6.
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